Consolidated EBITDA grew by 18.8% to Rs 326.5 crore in Q2 FY24 from Rs 274.9 crore in Q2 FY23. EBITDA margin improved to 25% in Q2 FY24 as against 24.1% in Q2 FY23.

As on 30 September 2023, the total borrowings less cash, bank balance and current investments was Rs 86.3 crore representing a net debt to equity ratio of 0.03. (out of which, borrowings worth $52 million is foreign currency denominated).

Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, commented: “The second quarter delivered strong performance after a steady first quarter of the fiscal year. We are pleased to report the highest ever revenue on a quarterly basis with profitability sustaining at high levels driven by higher patient volumes across our units.

HCCI continues to contribute significantly to the overall performance achieving the highest ever revenue and profitability on a quarterly basis, also supported by the new Radiation Oncology block which continues to see good traction.

The new entity NHIC has delivered strong growth this quarter led by significantly higher patient transactions and increased collections, remaining on track as per the plan. We have changed our company logo to align with our vision to offer integrated healthcare services to the mass market at the highest quality and a new motto to Take Care of all our patients.”

Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 19 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with over 5,820 operational beds and a capacity of over 6,090 beds.

The scrip hit a life-time high of Rs 1,182.85 in today’s intraday session on the BSE.